PPBT
Purple Biotech
NASDAQ: PPBT · HEALTHCARE · BIOTECHNOLOGY
$4.23
-6.90% today
Updated 2026-04-29
Market cap
$6.95M
P/E ratio
—
P/S ratio
58.08x
EPS (TTM)
$-54.00
Dividend yield
—
52W range
$4 – $29
Volume
0.0M
Purple Biotech (PPBT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-253.00 | $-512000.00 | $-4.53M | $-3.31M | $-6.26M | $-8.63M | $-8.48M | $-5.58M | $-12.09M | $-15.07M | $-16.73M | $-19.93M | $-14.37M | $-5.54M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $9000.00 | $10000.00 | $13000.00 | $16000.00 | $11000.00 | $156000.00 | $115000.00 | $228000.00 | $3000.00 | $0.00 | $3025.00 |
| Depreciation | — | — | — | $1000.00 | $2000.00 | $4000.00 | $7000.00 | $179000.00 | $235000.00 | $231000.00 | $201000.00 | $197000.00 | $186000.00 | — |
| Stock-based comp | — | $296000.00 | $88000.00 | $59000.00 | $400000.00 | $2.31M | $773000.00 | $1.27M | $2.65M | $2.08M | $2.41M | $1.88M | $582000.00 | $309000.00 |
| Free cash flow | $-253.00 | $-512000.00 | $-4.53M | $-3.32M | $-6.27M | $-8.64M | $-8.50M | $-5.59M | $-12.25M | $-15.19M | $-16.96M | $-19.93M | $-14.37M | $-5.54M |
| Investing cash flow | — | — | — | $-9000.00 | $-7.91M | $2.77M | $2.04M | $-449000.00 | $-49.59M | $13.41M | $19.91M | $13.88M | $509000.00 | — |
| Financing cash flow | $253.00 | $701000.00 | $5.82M | $12.63M | $10.42M | $3.00M | $7.79M | $5.23M | $68.49M | $1.51M | $1.11M | $5.45M | $6.77M | — |
| Dividends paid | — | — | — | $341000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — |